Vivoryon Therapeutics (Netherlands) Analysis
| VVY Stock | 2.02 0.02 0.98% |
Vivoryon Therapeutics NV is undervalued with Real Value of 2.23 and Hype Value of 2.02. The main objective of Vivoryon Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Vivoryon Therapeutics NV is worth, separate from its market price. There are two main types of Vivoryon Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vivoryon Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vivoryon Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Vivoryon Therapeutics stock is traded in Netherlands on Euronext Amsterdam, with the market opening at 09:00:00 and closing at 17:40:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Netherlands. Vivoryon Therapeutics is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. Vivoryon Stock trading window is adjusted to Europe/Amsterdam timezone.
Vivoryon |
Vivoryon Stock Analysis Notes
About 33.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.63. Vivoryon Therapeutics had not issued any dividends in recent years. For more information please call Ulrich Dauer at 49 345 555 9900 or visit https://www.vivoryon.com.Vivoryon Therapeutics Investment Alerts
| Vivoryon Therapeutics had very high historical volatility over the last 90 days | |
| Vivoryon Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 10.76 M. Net Loss for the year was (12.65 M) with profit before overhead, payroll, taxes, and interest of 9.2 M. | |
| Vivoryon Therapeutics generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by insiders |
Vivoryon Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 365.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vivoryon Therapeutics's market, we take the total number of its shares issued and multiply it by Vivoryon Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Vivoryon Profitablity
Vivoryon Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Vivoryon Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Vivoryon Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vivoryon Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vivoryon Therapeutics' profitability requires more research than a typical breakdown of Vivoryon Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.34) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.34. Technical Drivers
As of the 25th of November, Vivoryon Therapeutics has the Risk Adjusted Performance of 0.0068, coefficient of variation of (43,176), and Variance of 27.29. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vivoryon Therapeutics, as well as the relationship between them. Please validate Vivoryon Therapeutics information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Vivoryon Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 2.02 per share.Vivoryon Therapeutics Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vivoryon Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vivoryon Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Vivoryon Therapeutics Outstanding Bonds
Vivoryon Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vivoryon Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vivoryon bonds can be classified according to their maturity, which is the date when Vivoryon Therapeutics NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Vivoryon Therapeutics Predictive Daily Indicators
Vivoryon Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vivoryon Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Vivoryon Therapeutics Forecast Models
Vivoryon Therapeutics' time-series forecasting models are one of many Vivoryon Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vivoryon Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vivoryon Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Additional Tools for Vivoryon Stock Analysis
When running Vivoryon Therapeutics' price analysis, check to measure Vivoryon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivoryon Therapeutics is operating at the current time. Most of Vivoryon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivoryon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivoryon Therapeutics' price. Additionally, you may evaluate how the addition of Vivoryon Therapeutics to your portfolios can decrease your overall portfolio volatility.